晨间信号Morning Signal
《科学》 第393卷 第6812期 · 2026年8月13日 · 中文解读

研究人员努力改进非阿片类止痛药

Researchers struggle to improve nonopioid pain drugs · Jennie Erin Smith
约 9 分钟News在小程序里点播,20 到 60 分钟做好
这篇讲什么
本文探讨了新型钠通道阻滞剂在疼痛治疗中的局限性,以及研究人员为提高其疗效所做的努力。
原文开头
Studies probe the limits of new sodium channel blockers JENNIE ERIN SMITH I n the past decade, as opioids claimed nearly half a million lives across the United States, surgeons, dentists, and other clinicians have pined for pain relievers that work as well as hydrocodone or oxycodone but without the high risk of addiction and overdose. Last year, the U.S. Food and Drug Administration (FDA) approved suzetrigine, the first in a new class of drugs that promised pain relief approaching that of opioid pills without those concerns. Although both Nav1.7 and Nav1.8 showed promise as drug targets in lab studies, clinical research has pointed to the latter as the stronger bet. …
摘自《科学》(Science)第393卷 第6812期 · 2026年8月13日,Jennie Erin Smith。仅引用开头一小段供了解文章,版权归原刊所有,全文请阅读原刊。
晨间信号小程序码
微信扫码,在小程序里听完整版
不用登录先听一篇 · 或在微信搜索小程序 晨间信号
同期其他文章